scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1030000132 |
P356 | DOI | 10.1007/S100960050345 |
P698 | PubMed publication ID | 10517190 |
P50 | author | Antonio Salar | Q42409674 |
Jordi Carratala | Q56418051 | ||
P2093 | author name string | F Gudiol | |
J Peris | |||
A Grañena | |||
E González-Barca | |||
A Fernández-Sevilla | |||
P433 | issue | 8 | |
P304 | page(s) | 539-544 | |
P577 | publication date | 1999-08-01 | |
P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
P1476 | title | Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia | |
P478 | volume | 18 |
Q92293429 | Bacteremia in febrile cancer patients in Uganda |
Q36247827 | Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center |
Q45746480 | Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity |
Q40796585 | Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study. |
Q36870904 | Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia |
Q82508198 | Different Clinical Characteristics between Polymicrobial and Monomicrobial Aeromonas Bacteremia -A Study of 216 Cases |
Q37192118 | Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center. |
Q42242524 | Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. |
Q34390823 | European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia |
Q34676431 | Evaluation of febrile neutropenic episodes in adult patients with solid tumors |
Q33846201 | How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy |
Q34614712 | Incidence of hospital-acquired pneumonia, bacteraemia and urinary tract infections in patients with haematological malignancies, 2004-2010: a surveillance-based study |
Q33588190 | Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients |
Q37345694 | Lung infections after cancer chemotherapy |
Q82323531 | Meta-Analysis of Randomized Controlled Trials of Granulocyte Colony-Stimulating Factor Prophylaxis in Adult Cancer Patients Receiving Chemotherapy |
Q34566114 | Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients |
Q34557550 | Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study |
Q42766829 | Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy |
Q38006021 | Pharmacoeconomics of the myeloid growth factors: a critical and systematic review |
Q54210313 | Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections. |
Q42013683 | Prognostic indexes of septic syndrome in the emergency department |
Q44589566 | Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center |
Q40081509 | Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers |
Q40212712 | Role of interleukin-6 in differentiating interleukin-11 induced fever and early bacterial infection |
Q36038909 | Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode. |
Search more.